Doubling of IL medical cannabis users expected as opioid-option program starts

Women, minority execs show few gains in U.S. cannabis industry, according to the latest data from the MJBiz Diversity, Inclusion and Equity Report. Get your copy here.


An industry observer predicted the growing Illinois medical marijuana program will see a surge in the number of MMJ patients as a result of a pilot opioid-alternative program that launched Thursday.

Dan Linn, executive director of NORML’s Illinois chapter, told The State Journal-Register in Springfield that he expects the program to contribute to a doubling of the number of MMJ users in the state over the next year.

Illinois already has seen steady growth, with dispensary sales exceeding $130 million in 2018.

Medical marijuana companies prepared for a boom in business as Illinois MMJ users began enrolling in a program designed to cut opioid addiction and overdoses.

For more details on Illinois’ opioid-alternative launch, click here.